Agoraphobia treated with
**Core Concept**
Agoraphobia is a type of anxiety disorder characterized by fear of being in public places or situations where escape might be difficult. This fear leads to avoidance of such situations, resulting in significant distress or impairment in social, occupational, or other areas of functioning. The pathophysiology of agoraphobia involves hyperactivity of the amygdala, excessive release of stress hormones like cortisol and adrenaline, and altered functioning of the brain's default mode network.
**Why the Correct Answer is Right**
The first-line treatment for agoraphobia is cognitive-behavioral therapy (CBT), particularly exposure therapy. Exposure therapy involves gradually exposing the patient to the feared situation, helping them learn to cope with the associated anxiety. This type of therapy is effective in reducing symptoms of agoraphobia by modifying maladaptive thought patterns and behaviors. Another treatment option is selective serotonin reuptake inhibitors (SSRIs), which can help alleviate anxiety symptoms by increasing serotonin levels in the brain.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because benzodiazepines are not a recommended treatment for agoraphobia due to their potential for dependence and abuse.
**Option B:** This option is incorrect because beta blockers are not effective in treating the underlying anxiety disorder of agoraphobia, although they may provide temporary relief from physical symptoms like tremors.
**Option C:** This option is incorrect because tricyclic antidepressants (TCAs) are not a first-line treatment for agoraphobia and can have significant side effects.
**Clinical Pearl / High-Yield Fact**
A key aspect of treating agoraphobia is to focus on the patient's thoughts and behaviors associated with avoidance, rather than just the anxiety symptoms themselves. This can be achieved through techniques like cognitive restructuring and exposure therapy.
**Correct Answer:** C.